Cubist Systematic Strategies’s Cullinan Oncology CGEM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-130,647
| Closed | -$1.59M | – | 1570 |
|
|
2024
Q4 | $1.59M | Buy |
+130,647
| New | +$1.59M | 0.01% | 674 |
|
|
2024
Q2 | – | Sell |
-55,888
| Closed | -$952K | – | 1618 |
|
|
2024
Q1 | $952K | Sell |
55,888
-1,038
| -2% | -$17.7K | 0.01% | 1170 |
|
|
2023
Q4 | $580K | Buy |
56,926
+24,294
| +74% | +$248K | ﹤0.01% | 1325 |
|
|
2023
Q3 | $295K | Buy |
32,632
+26,584
| +440% | +$241K | ﹤0.01% | 1422 |
|
|
2023
Q2 | $65.1K | Buy |
+6,048
| New | +$65.1K | ﹤0.01% | 1877 |
|
|
2022
Q4 | – | Sell |
-14,015
| Closed | -$180K | – | 3306 |
|
|
2022
Q3 | $180K | Sell |
14,015
-92,675
| -87% | -$1.19M | ﹤0.01% | 3038 |
|
|
2022
Q2 | $1.37M | Buy |
106,690
+91,164
| +587% | +$1.17M | 0.01% | 1874 |
|
|
2022
Q1 | $163K | Buy |
15,526
+3,610
| +30% | +$37.9K | ﹤0.01% | 3080 |
|
|
2021
Q4 | $184K | Buy |
+11,916
| New | +$184K | ﹤0.01% | 3058 |
|